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CPAPAbstract Background: Gastro-esophageal reﬂux disease and obstructive sleep apnea syndrome
are often co-morbid disorders. Frequency of GERD among OSAS patients and its response to
CPAP treatment need to be clariﬁed.
Objectives: To determine the prevalence of GERD among OSAS patients and to assess its
response to CPAP treatment.
Methods: 30 patients were diagnosed as having OSAS and 15 healthy subjects selected as the
controlled group underwent upper GI endoscopy. Then the effect of 6 months CPAP treatment
on GERD in OSAS patients was assessed.
Results: The frequency of GERD in patients with OSAS was signiﬁcantly higher than in controls
(43.3% versus 13.3%, p= 0.044). The heartburn and regurgitation in patients with OSAS were sig-
niﬁcantly higher than controls (p= 0.015 and 0.048 respectively), while the difference in dysphagia
was non signiﬁcant (p= 0.526).
The differences in heartburn and regurgitation in OSAS patients with GERD were signiﬁcantly
higher than OSAS patients without GERD (p= 0.002 and 0.001 respectively), but the difference in
dysphagia was non signiﬁcant (p= 0.806). After CPAP treatment for 6 months, GERD was cured
in 8 patients out of 13 patients (61.4%).
Conclusion: GERD occurs more common in OSAS patients as compared to controls. There was
positive impact that CPAP treatment reduces GERD in patients with OSAS by 61.5%.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The occurrence of gastro esophageal reﬂux disease (GERD)
after bed time is strongly associated with both asthma and
obstructive sleep apnea syndrome (OSAS). It has been found
that patients with OSAS exhibited more frequent nocturnal
reﬂux symptoms than patients without OSAS [1]. It has beenrculosis.
Table 1 Distribution of GERD symptoms between patients
with OSAS and controls.
Patients with
OSAS
(n= 30)
Controls
(n= 15)
Z test P value
No. % No. %
Heart burn 19 63.3 3 20.0 2.42 0.015(S)
Regurgitation 12 40.0 1 6.7 1.97 0.048(S)
Dysphagia 3 10.0 0 0.0 0.63 0.526
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ment of nocturnal GERD because apneic episodes are associ-
ated with increased arousal movement and increased trans-
diaphragmatic pressure as well as low intrathoracic pressure
[2]. Foresman (2000) found that patientswithOSASexperienced
more than one hundred reﬂux episodes during the 8-h sleep per-
iod compared with twenty-three reﬂux episodes in the control
subjects withoutOSAS [3]. Also, Ing et al. (2000) postulated that
esophageal acid clearance was prolonged with signiﬁcantly
greater proportion of time at low esophageal pH in OSAS
patients compared to non OSAS patients [4]. Kerr and col-
leagues (1992) reported that continuous positive airway pressure
(CPAP) treatment reduced GERD in patients with OSAS [5].
Aim of the work
The aim of this work was to determine the prevalence of
GERD among OSAS patients and to assess its response to
CPAP treatment.
Patients and methods
This study was performed in on forty ﬁve subjects referred to
the Chest Medicine Department of Menouﬁa University
Hospitals, All subjects underwent initial polysomnography to
determine the presence of obstructive sleep apnea hypopnea
syndrome. Then all patients underwent upper GI endoscopy
carried out in the Tropical Medicine Department of
Menouﬁa University Hospitals. Then the response of 6 months
CPAP treatment on GERD was assessed in OSAS patients.
Subjects were divided into:
Group 1 (patients): 30 patients with OSAS as evidenced by
polysomnography (AHI > 5/h).
Group 2 (controls): 15 subjects without OSAS as evidenced
by polysomnography (AHI < 5/h).
After having a written consent; each patient underwent:
(1) Full history taking and clinical examination.
(2) Chest X-ray.
(3) Polysomnography: Polysomnography includes EEG,
electrooculogram and sub mental electromyogram mon-
itoring for sleep staging. Respirations were monitored
using chest and abdominal Impedance plethysmogra-
phy. Airﬂow was assessed with oronasalthermistor.
Arterial oxygen saturation was monitored with continu-
ous pulse oximetry, Heart rate and rhythm were
recorded and monitored with continuous ECG.
Periodic limb movements were monitored using bilateral
tibial electromyography leads. Polysomnography used
in this study is a full night polysomnography using
Embla S4000 Medcare, Iceland. It was conducted in
the sleep laboratory, Menouﬁa University Hospital.
(4) Upper GI endoscopy.
(5) CPAP for 6 months of ﬁrst GI endoscopy to patients
with GERD.
Results
Table 1 shows that heartburn and regurgitation in patients
with OSA were signiﬁcantly higher than controls (p= 0.015and 0.048 respectively) while the difference in dysphagia was
statistically non signiﬁcant (p= 0.526) (Fig. 1).
Table 2 shows that the frequency of GERD in patients with
OSAS was signiﬁcantly higher than in controls (43.3% versus
13.3%, p= 0.044) (Fig. 2).
Table 3 shows that the differences in heartburn and regur-
gitation in OSAS patients with GERD were signiﬁcantly
higher than OSAS patients without GERD (p= 0.002 and
0.001 respectively), but the difference in dysphagia was statis-
tically non signiﬁcant (p= 0.806).
Table 4 shows that after CPAP treatment for 6 months,
GERD was cured in 8 patients out of 13 patients (61.4%).
Discussion
OSAS is a condition marked by pharyngeal narrowing, result-
ing in upper airway obstruction during sleep which in turn,
produces repeated episodes of decreased oxygen saturation
and brief arousals from sleep. Currently, sleep related
GERD is underappreciated from a clinical standpoint.
Gastro-esophageal reﬂux disease and obstructive sleep apnea
syndrome are often co-morbid disorders [6,7].
The aim of this study was to determine the prevalence of
gastroesophageal reﬂux in patients with obstructive sleep
apnea and to assess its response to CPAP treatment. This
prospective study comprised 30 patients with OSAS and 15
controls (without OSAS).
In the present study, the heartburn and regurgitation were
signiﬁcantly higher in patients with OSAS as compared to con-
trols (p= 0.015 and 0.048 respectively), Heart burn in patients
with OSAS versus controls was 63,3% versus 20% and regur-
gitation in patients with OSAS versus controls was 40% versus
6.7% while dysphagia showed no signiﬁcant difference
(p= 0.526). Dysphagia in patients with OSAS versus controls
was 10% versus 0.0% (Table 1). This conﬁrmed the common
existence of classic symptoms of GERD (heartburn and regur-
gitation) in patients with OSAS in comparison to those with-
out OSAS. This was in accordance to Teramoto et al. (1999)
[8], Valipour et al. (2002) [9]), Green et al. (2003) [10] and
Guda et al. (2004) [11], who reported a signiﬁcant increase in
reﬂux symptoms in patients with demonstrated OSAS.
There were signiﬁcantly higher frequency of GERD in
patients with OSAS versus controls (43.3% versus 13.3%,
p= 0.044) (Table 2). These were in agreement with Penzel
et al. (1999) [12] who found reﬂux in 53.3% (8 out of 15) of
patients with OSAS. Berg et al. (1999) [13] reported reﬂux in
6 out of 14 (42.9%) patients with OSAS. Wise et al. (2006)
[14] reported that 64.3% of patients with OSAS had GERD.
Several other studies showed higher incidence of GERD in
Table 3 Distribution of GERD symptoms in OSAS patients
with GERD versus OSAS patients without GERD.
OSAS patients Z test P value
With GERD
(n= 13)
Without GERD
(n= 17)
No. % No. %
Heart burn 13 100.0 7 41.2 2.99 0.002(S)
Regurgitation 10 76.9 2 11.8 3.23 0.001(S)
Dysphagia 2 15.4 1 5.9 0.25 0.806
Figure 1 Frequency of GERD in patients with OSAS versus
controls.
Table 2 Distribution of GERD in patients with OSAS versus
controls.
Patients with OSAS
(n= 30)
Controls
(n= 15)
v2 test P value
No. % No. %
GERD
Present 13 43.3 2 13.3 4.05 0.044(S)
Absent 17 56.7 13 86.7
Table 4 Effect of 6 months CPAP treatment on GERD in
OSAS patients.
CPAP OSAS patients with GERD (n= 13)
No. %
Not cured 5 38.6
Cured 8 61.4
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Senior et al. (2001) [15] and Suganuma et al. (2001) [16].
Heartburn and regurgitation in OSAS patients with GERD
were signiﬁcantly higher than in OSAS patients without
GERD (p= 0.002 and 0.001 respectively) Heartburn in
OSAS patients with GERD versus in OSAS patients without
GERD was 100% versus 41.2% and regurgitation in OSAS
patients with GERD versus OSAS patients without GERD
was 76.9% versus 11.8% while the dysphagia showed no sig-
niﬁcant difference (p= 0.860), Dysphagia in OSAS patients
with GERD versus OSAS patients without GERD was
15.4% versus 5.9% (Table 3). This illustrates that the heart-
burn and regurgitation were reliable symptoms for diagnosis
of GERD in OSAS patients while dysphagia was of less impor-
tance. This was in accordance to Martinez et al. (2003) [17],Figure 2 Effect of 6 months CPAP treatment in GERD in OSAS
patients.who reported that dysphagia had no association with abnor-
mal 24 h PH studies while heartburn and regurgitation were
positively associated with abnormal 24 h PH monitoring.
Multiple investigators noted the validity of establishing
GERD on the basis of symptoms as Coyne et al. (2003) [18],
Pare et al. (2003) [19] and Kim et al. (2005) [20].
After CPAP treatment for 6 months, GERD was reduced
from 13 patients to 5 patients by 61.4% (Table 4). Our study
was in agreement with Green BT et al. (2003) [10] who found
that of the 331 patients with OSAS, nocturnal GERD was pre-
sent in 204 (62%) before treatment with CPAP. Follow-up was
obtained in 181 patients (89%). Of these 181 patients, 165
(91%) were still using CPAP and 16 (9%) were not, forming
the treatment and control groups, respectively. The patients
compliant with CPAP had a signiﬁcant improvement in noc-
turnal GERD score, from a mean of 3.38 before CPAP treat-
ment to 1.75 after treatment (48% improvement; P< .001),
while patients not using CPAP (control subjects) showed no
improvement (mean of, 3.56–3.44; P= 0.55). There was a
strong correlation between CPAP pressure and improvement
in GERD score (correlation, r= 0.70; P< .001).
Conclusion
From the present study we can conclude that GERD occurs
more common in OSAS patients as compared to controls
(43.3% versus 13.3%). There was a positive impact that con-
tinuous positive airway pressure (CPAP) treatment reduces
GERG in patients with OSAS by 61.5%.
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